DE3875647D1 - Verwendung von 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. - Google Patents

Verwendung von 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.

Info

Publication number
DE3875647D1
DE3875647D1 DE8888106677T DE3875647T DE3875647D1 DE 3875647 D1 DE3875647 D1 DE 3875647D1 DE 8888106677 T DE8888106677 T DE 8888106677T DE 3875647 T DE3875647 T DE 3875647T DE 3875647 D1 DE3875647 D1 DE 3875647D1
Authority
DE
Germany
Prior art keywords
imidazoline
pyridyl
phenyl
ethyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888106677T
Other languages
English (en)
Other versions
DE3875647T2 (de
Inventor
Yasumasa Yoshie
Setsuo Kobayashi
Tsugio Nakazawa
Yasushi Abiko
Kinya Kameda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3875647D1 publication Critical patent/DE3875647D1/de
Publication of DE3875647T2 publication Critical patent/DE3875647T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888106677T 1987-04-27 1988-04-26 Verwendung von 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. Expired - Fee Related DE3875647T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10372787 1987-04-27

Publications (2)

Publication Number Publication Date
DE3875647D1 true DE3875647D1 (de) 1992-12-10
DE3875647T2 DE3875647T2 (de) 1993-03-18

Family

ID=14361688

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888106677T Expired - Fee Related DE3875647T2 (de) 1987-04-27 1988-04-26 Verwendung von 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.

Country Status (15)

Country Link
US (1) US4874772A (de)
EP (1) EP0288978B1 (de)
KR (1) KR880012228A (de)
AT (1) ATE81974T1 (de)
AU (1) AU611145B2 (de)
CA (1) CA1309027C (de)
DE (1) DE3875647T2 (de)
DK (1) DK226688A (de)
ES (1) ES2052634T3 (de)
GR (1) GR3006610T3 (de)
HU (1) HU203665B (de)
IL (1) IL86151A (de)
NO (1) NO881798L (de)
PH (1) PH24155A (de)
ZA (1) ZA882737B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
JPS60123418A (ja) * 1983-12-07 1985-07-02 Dai Ichi Seiyaku Co Ltd 血管拡張剤

Also Published As

Publication number Publication date
AU1519088A (en) 1988-10-27
KR880012228A (ko) 1988-11-26
ES2052634T3 (es) 1994-07-16
AU611145B2 (en) 1991-06-06
DK226688A (da) 1988-10-28
EP0288978A3 (en) 1990-02-21
US4874772A (en) 1989-10-17
DE3875647T2 (de) 1993-03-18
ATE81974T1 (de) 1992-11-15
EP0288978A2 (de) 1988-11-02
PH24155A (en) 1990-03-22
NO881798D0 (no) 1988-04-25
GR3006610T3 (de) 1993-06-30
IL86151A (en) 1993-04-04
DK226688D0 (da) 1988-04-26
NO881798L (no) 1988-10-28
HUT46537A (en) 1988-11-28
IL86151A0 (en) 1988-11-15
ZA882737B (en) 1988-10-17
HU203665B (en) 1991-09-30
CA1309027C (en) 1992-10-20
EP0288978B1 (de) 1992-11-04

Similar Documents

Publication Publication Date Title
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
PT93333A (pt) Processo de preparacao de uma composicao biocida sinergica e de tratamento usando a referida composicao
DE3585607D1 (de) Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
ATE109350T1 (de) Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie.
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
PT86859A (pt) Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE3875647D1 (de) Verwendung von 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DK16985A (da) Leukotrienantagonister samt fremgangsmaade til fremstilling heraf
NO911237D0 (no) Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner.
DE3584426D1 (de) Verwendung von spergualin oder eines seiner pharmazeutisch akzeptablen salze zur herstellung eines transplantation-immunitaet unterdrueckenden und anti-allergischen mittels.
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
DE59203472D1 (de) Verwendung von dl-valin, dessen estern und/oder salzen zur bekämpfung von kopfschuppen.
DE59002266D1 (de) Verwendung von 4-(hydroxydi-phenylmethyl)-1-piperidyl-phenylalkan-derivaten zur herstellung eines antihistaminikums.
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee